Rapid Development of Neutralizing and Diagnostic SARS-COV-2 Mouse Monoclonal Antibodies
A. P. Chapman, X. Tang, J. R. Lee, A. Chida, K. Mercer, R. E. Wharton, M. H. Kainulainen, J. L. Harcourt, R. B. Martines, M. Schroeder, L. Zhao, A. Bryksin, B. Zhou, E. Bergeron, B. C. Bollweg, , J. M. Goldstein
This study develops and characterizes high-affinity mouse monoclonal antibodies against SARS-CoV-2, showing their neutralizing and diagnostic potential.
bioRxiv · Oct 13, 2020Immunology